AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE AS A PATHOGENETIC MARKER OF TYPE I DIABETES MELLITUS
https://doi.org/10.15789/1563-0625-2011-2-3-257-260
Abstract
Abstract. A new method of enzyme-linked immunosorbent assay (in solid-phase ELISA format) has been developed to determine concentrations of autoantibodies to glutamic acid decarboxylase, as well as an evidencebased methodology is proposed for its medical implications, as a quantitative pathogenetic predictive marker of autoimmune diagnostics in type 1 diabetes mellitus. This technique could be implied for serial production of diagnostic reagent kits, aimed for detection of autoantibodies to glutamic acid decarboxylase by means of ELISA approach. (Med. Immunol., 2011, vol. 13, N 2-3, pp 257-260)
About the Authors
N. V. Piven
ГНУ «Институт биоорганической химии НАН Беларуси», г. Минск
Russian Federation
Russian Federation
L. N. Lukhverchyk
ГНУ «Институт биоорганической химии НАН Беларуси», г. Минск
Russian Federation
Russian Federation
A. I. Burakovsky
ГНУ «Институт биоорганической химии НАН Беларуси», г. Минск
Russian Federation
Russian Federation
N. V. Polegenkaya
ГНУ «Институт биоорганической химии НАН Беларуси», г. Минск
Russian Federation
Russian Federation
M. V. Karpovich
ГНУ «Институт биоорганической химии НАН Беларуси», г. Минск
Russian Federation
Russian Federation
References
1. Пивень Н.В., Орлова Е.Е. Аутоантитела к декарбоксилазе глютаминовой кислоты как маркеры развития сахарного диабета (обзор) // Сб. «Биорегуляторы: исследование и применение». – 2008. – № 2. – С. 78-83.
2. Пивень Н.В., Орлова Е.Е., Лухверчик Л.Н. Иммуноферментный анализ аутоантител к декарбоксилазе глютаминовой кислоты – маркера сахарного диабета 1 типа // Вестник фонда фундаментальных исследований. – 2010. – № 1. – С. 70-77.
3. Kimpim ki T.., Kulmala P.., Savola K.., Kupila A., Korhonen S., Simell T., Ilonen J., Simell O., Knip M. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population // J. Clin. Endocrinol. Metab. – 2002. – Vol. 87. – P. 4572-4579.
4. Crowther J.R. The ELISA Guidebook. – New Jersey: Humana Press, 2001. – 421 p.
5. Mayr A., Schlosser M., Grober N., Kenk H., Ziegler A.G., Bonifacio E., Achenbach P.. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type I diabetes // Diabetes. – 2007. – Vol. 56, N 6. – P. 1527-33.
6. Pihoker C., Gilliam L.K., Hampe C.S., Lernmark A. Autoantibodies in diabetes // Diabetes. – 2005. – Vol. 54, N 2. – P. 61-52.
7. Sabbah E. Role of antibodies to glutamic acid decarboxylase in type 1 diabetes // Oulu. – 2000. – P. 17-34.
8. Viglietta V., Kent S.C., Orban T., Hafler D.A. GAD 65-reactive T cells are activated in patients with autoimmune type 1 diabetes // The Journal of Clinical Investigation. – 2002. – Vol. 109, N 7. – P. 895-903.
Review
For citations:
Piven N.V., Lukhverchyk L.N., Burakovsky A.I., Polegenkaya N.V., Karpovich M.V. AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE AS A PATHOGENETIC MARKER OF TYPE I DIABETES MELLITUS. Medical Immunology (Russia). 2011;13(2-3):257-260. (In Russ.) https://doi.org/10.15789/1563-0625-2011-2-3-257-260
Views:
1020
Email this article 